Flu vaccines were once a business that many drug companies avoided, but that segment of the pharma industry is now firmly in the spotlight. CNBC's Mike Huckman visits the only injectable flu vaccine plant in the US for a behind-the-scenes look.
¿This has become a stock picker¿s market within the equity market,¿ Khuram Chaudhry from BofA Merrill Lynch Global Research said Friday, adding that this is dependent on the earnings season and companies¿ outlooks. ¿But the overall guidance in terms...
...